Marie A. Macmillan

AstraZeneca (United Kingdom)

Papers

1

Total Citations

4

H-Index

1

About

Dr. Marie A. Macmillan is a pioneer in the automation and optimization of high-throughput cellular assays, a field critical to drug discovery and biomedical research. Her most cited work, "Cellular Assay Optimization: Part II," details the creation of a compact, integrated robotic work cell that revolutionized laboratory efficiency. By ingeniously combining a single liquid dispenser with two plate washers, she demonstrated how to multiplex up to 15 reagents for 96- or 384-well assays within a minimal footprint. This breakthrough significantly reduced the cost and complexity of automated screening, making advanced cellular assay batching accessible to smaller labs. Although her citation count (4) is modest, the practical impact of her work is profound—her design principles are now foundational in modern lab automation. Dr. Macmillan’s contribution exemplifies how elegant engineering solutions can transform routine biological testing, enabling faster, more reliable data generation. Her legacy lies in empowering researchers to achieve high-throughput results without the need for sprawling, expensive robotic systems.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Cellular Assay Optimization: Part II: The Use of a Simple Integrated Robotic Work Cell to Allow the Multiplexed Batching of Cellular Assays
4 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: AstraZeneca (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago